首页 | 本学科首页   官方微博 | 高级检索  
检索        

舍曲林与马普替林治疗脑梗死后抑郁对照研究
引用本文:顾卫霞,董伟,陈慧.舍曲林与马普替林治疗脑梗死后抑郁对照研究[J].中国民康医学,2008,20(21):2491-2492.
作者姓名:顾卫霞  董伟  陈慧
作者单位:1. 江苏省扬州五台山医院,江苏,扬州,225003
2. 江苏省苏北人民医院
摘    要:目的:探讨舍曲林治疗脑梗死后抑郁的疗效及安全性。方法:将60名脑梗死后抑郁患者随机分为两组,分别给予舍曲林和马普替林治疗,疗程6周。采用汉密尔顿抑郁量表(HAMD)评定疗效、治疗中出现的症状量表(TESS)评价安全性。结果:舍曲林治疗脑梗死后抑郁与马普替林疗效相当,但舍曲林起效更快,不良反应更少。结论:舍曲林治疗脑梗死后抑郁安全有效。

关 键 词:舍曲林  马普替林  脑梗死  抑郁

A Comparative Study of Sertraline and Maprotiline in the treatment of Post-cerebral-infarction Depression
GU Wei-xia,DONG Wei,CHEN Hui.A Comparative Study of Sertraline and Maprotiline in the treatment of Post-cerebral-infarction Depression[J].medical journal of chinese peoples health,2008,20(21):2491-2492.
Authors:GU Wei-xia  DONG Wei  CHEN Hui
Abstract:Objective:To explore the efficacy and safety of Sertraline to treat post-cerebral infarction depression(PID).Methods:60 patients with PID were randomly divided into two equivalent groups.Respectively given them Sertraline and Maprotiline for 6 weeks.The efficacy were assessed by Hamilton Depression Rating Scale(HAMD)and the safety was assessed by treatment emergent symptoms scale(TESS).Results: The overall curative effects were similar in patients of the two groups.However,Sertraline acts more rapidly and less clinical adverse reaction than maprotiline.Conclusions: Sertraline is effective and safe for the treatment of PID.
Keywords:Sertraline  Maprotiline  Cerebral infarction  Depression
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号